• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

McKesson Corporation Announces Third-Quarter Fiscal 2023 Earnings Release Date

Share:

January 2, 2023

McKesson Corporation (NYSE: MCK) will release its third-quarter fiscal 2023 financial results after market close on Wednesday, February 1, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

The live webcast will be available on McKesson’s Investor Relations website at http://investor.mckesson.com, along with the company’s earnings release, financial tables and slide presentation.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • How Digital Tools Are Helping Unlock M&A ValueHow Digital Tools Are Helping Unlock M&A Value
  • 10 of the Hottest Life Sciences SPAC Merger Announcements So Far This Year10 of the Hottest Life Sciences SPAC Merger Announcements So Far This Year
  • Safeguard Scientifics Partner Company Propeller Health Acquired By ResMedSafeguard Scientifics Partner Company Propeller Health Acquired By ResMed
  • MeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy Program for Parkinson’s DiseaseMeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy Program for Parkinson’s Disease
  • Bioventus Amends Cartiheal Acquisition StructureBioventus Amends Cartiheal Acquisition Structure
  • Pasha Brands Acquires Health Canada Approved Processor and CultivatorPasha Brands Acquires Health Canada Approved Processor and Cultivator
  • AI And Healthcare: A Giant OpportunityAI And Healthcare: A Giant Opportunity
  • Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 MillionNeurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications